Gesynta Pharma’s Investment Round

Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal.Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here